1. Patients launch a $1.27 million crowdfunding campaign for ME/CFS gut microbiome study.
    Check out the website, Facebook and Twitter. Join in donate and spread the word!
In Brief: The Adrenal Glands and ME
The second in a new series of ‘In Brief’ articles, where Andrew Gladman provides a helpful insight into the science behind fairly common topics, exploring how they relate to ME/CFS. This time he discusses the adrenal glands and why they can be such a talking point ...
Discuss the article on the Forums.

Initial Montoya valcyte study

Discussion in 'Antivirals, Antibiotics and Immune Modulators' started by heapsreal, Jun 21, 2011.

  1. heapsreal

    heapsreal iherb 10% discount code OPA989,

    Messages:
    6,517
    Likes:
    3,455
    australia (brisbane)
    The initial study of 25 showed dramatic improvement in 21 patients. Does anyone know or in contact with anyone in that initial study and can report back on how they are going now. Are they still greatly improved or had to go back on av's etc?

    Also interested to hear from others who have greatly improved on valcyte and able to maintain most of this progress when off valcyte.

    cheers!!!
  2. undcvr

    undcvr Senior Member

    Messages:
    760
    Likes:
    112
    NYC
    U hv the link to that ? That's an unbelievably hi success rate. How long were his patients on the AVs for ?

    And what does it mean that if you come off the AVs and you relapse ? Does it mean that there is something else behind the CFS besides the Herpesvirus or does it mean that you just need a longer time on it for it to work ? At least Lerner seems to think so but he worked out a period of 7 years before it is completely gone from the body.
  3. heapsreal

    heapsreal iherb 10% discount code OPA989,

    Messages:
    6,517
    Likes:
    3,455
    australia (brisbane)
    no link but easy to find in a google. It was his initial valcyte study(2007?), but his second study wasnt as successful, they think due to other co-infections. The first study i think were hand picked with just hhv6/ebv. And yes i think montoya does now think that 6 months is to short for treatment and i believe he was in contact with lerner. I think the way montoya is studying alot more pathogens in cfs through stanford that he is probably going to group patients into sub groups accordingly. Reading through a few old threads i believe that montoya starts patients on alot lower doses now and slowly builds up as this helps avoid negative reactions that have occurred in some, would be good if someone could clarify this for us.

    cheers!!!

See more popular forum discussions.

Share This Page